World's Best Scientists 2026 revealed!
Thomas A. D'Amico

Thomas A. D'Amico

D-Index & Metrics

Medicine

D-Index
86
Citations
37369
World Ranking
13907
National Ranking
7061

Overview

Thomas A. D'Amico is affiliated with Duke University in the United States and has an extensive research portfolio in the field of Medicine with particular emphasis on pulmonary and respiratory medicine, surgery, and oncology. Their work encompasses a variety of clinical and research topics related to lung, esophageal, and gastric cancers.

Their main fields of study include:

  • Medicine

Within this overarching field, their subfields of study focus on:

  • Pulmonary and Respiratory Medicine
  • Surgery
  • Oncology
  • Public Health, Environmental and Occupational Health
  • Radiology, Nuclear Medicine and Imaging

The primary topics of Thomas A. D'Amico's research contributions include:

  • Lung Cancer Diagnosis and Treatment
  • Esophageal Cancer Research and Treatment
  • Gastric Cancer Management and Outcomes
  • Lung Cancer Treatments and Mutations
  • Esophageal and GI Pathology
  • Radiomics and Machine Learning in Medical Imaging
  • Lung Cancer Research Studies

The scientist has published extensively in several distinguished academic venues. The frequent publication venues include:

  • The Annals of Thoracic Surgery
  • Journal of Thoracic and Cardiovascular Surgery
  • Seminars in Thoracic and Cardiovascular Surgery
  • Annals of Surgery
  • Journal of the National Comprehensive Cancer Network

Among recent papers authored or coauthored by Thomas A. D'Amico are:

  • "Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology," published in 2022 in the Journal of the National Comprehensive Cancer Network
  • "Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology," published in 2022 in the Journal of the National Comprehensive Cancer Network
  • "NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021," published in 2021 in the Journal of the National Comprehensive Cancer Network
  • "Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology," published in 2023 in the Journal of the National Comprehensive Cancer Network
  • "Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology," published in 2021 in the Journal of the National Comprehensive Cancer Network

Frequent coauthors who have collaborated extensively with Thomas A. D'Amico include:

  • Betty C. Tong
  • Vignesh Raman
  • Robert M. Sade
  • David H. Harpole
  • John W. Entwistle

Best Publications

  • Non–Small Cell Lung Cancer

    David S. Ettinger;Wallace Akerley;Gerold Bepler;Andrew Chang

  • Non-small cell lung cancer, version 5.2017: Clinical practice guidelines in oncology

    David S. Ettinger;Douglas E. Wood;Dara L. Aisner;Wallace Akerley

  • Gastric Cancer, Version 3.2016; Clinical Practice Guidelines in Oncology

    Jaffer A. Ajani;Thomas A. D'Amico;Khaldoun Almhanna;David J. Bentrem

  • Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: A propensity-matched analysis from the STS database

    Subroto Paul;Nasser K. Altorki;Shubin Sheng;Paul C. Lee

  • Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.

    Jaffer A. Ajani;Thomas A. D'Amico;David J. Bentrem;Joseph Chao

  • Non-small cell lung cancer, version 1.2020: Featured updates to the NCCN guidelines

    David S. Ettinger;Douglas E. Wood;Charu Aggarwal;Dara L. Aisner

  • NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021

    David S. Ettinger;David S. Ettinger;Douglas E. Wood;Douglas E. Wood;Dara L. Aisner;Wallace Akerley;Wallace Akerley

  • Video-Assisted Thoracic Surgery Lobectomy: Report of CALGB 39802—A Prospective, Multi-Institution Feasibility Study

    Scott J. Swanson;James E. Herndon;Thomas A. D'Amico;Todd L. Demmy

  • Gastric Cancer, Version 2.2013

    Jaffer A. Ajani;David J. Bentrem;Stephen Besh;Thomas A. D'Amico

  • Reducing hospital morbidity and mortality following esophagectomy

    B.Zane Atkins;Ashish S. Shah;Kelley A. Hutcheson;Jennifer H. Mangum

  • Non-small cell lung cancer: Clinical practice guidelines in oncology

    David S. Ettinger;Wallace Akerley;Gerold Bepler;Matthew G. Blum

  • Thoracoscopic Lobectomy Is a Safe and Versatile Procedure: Experience With 500 Consecutive Patients

    Mark W. Onaitis;Rebecca P. Petersen;Stafford S. Balderson;Eric Toloza

  • Non-small cell lung cancer, version 2.2013: Featured updates to the NCCN guidelines

    David S. Ettinger;Wallace Akerley;Hossein Borghaei;Andrew C. Chang

  • Non–Small Cell Lung Cancer, Version 6.2015

    David S. Ettinger;Douglas E. Wood;Wallace Akerley;Lyudmila A. Bazhenova

  • NCCN Guidelines ® Insights: Non-Small Cell Lung Cancer, Version 4.2016 Featured Updates to the NCCN Guidelines

    David S. Ettinger;Douglas E. Wood;Wallace Akerley;Lyudmila A. Bazhenova

  • NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 5.2018

    David S. Ettinger;Dara L. Aisner;Douglas E. Wood;Wallace Akerley

  • Thoracoscopic lobectomy is associated with lower morbidity compared with thoracotomy.

    Nestor R. Villamizar;Marcus D. Darrabie;William R. Burfeind;Rebecca P. Petersen

  • Esophageal and esophagogastric junction cancers, version 1.2015.

    Jaffer A. Ajani;Thomas A. D'Amico;Khaldoun Almhanna;David J. Bentrem

  • Thoracoscopic Lobectomy Facilitates the Delivery of Chemotherapy after Resection for Lung Cancer

    Rebecca P. Petersen;Duy Khanh Pham;William R. Burfeind;Steven I. Hanish

  • Malignant pleural mesothelioma.

    David S. Ettinger;Wallace Akerley;Hossein Borghaei;Andrew Chang

Frequent Co-Authors

David H. Harpole
David H. Harpole Duke University
Gregory A. Otterson
Gregory A. Otterson The Ohio State University
Mark B. Orringer
Mark B. Orringer University of Michigan–Ann Arbor
David S. Ettinger
David S. Ettinger Johns Hopkins University
Lawrence B. Marks
Lawrence B. Marks University of North Carolina at Chapel Hill
Lucian R. Chirieac
Lucian R. Chirieac Brigham and Women's Hospital
Gregory J. Riely
Gregory J. Riely Memorial Sloan Kettering Cancer Center
Christopher G. Willett
Christopher G. Willett Duke University
Ramaswamy Govindan
Ramaswamy Govindan Washington University in St. Louis
John E. Mayer
John E. Mayer Boston Children's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative online degrees and career pathways can provide valuable options for those interested in the medical field without taking the traditional route of studying Medicine in the USA. Many students are drawn to roles like medical billing or coding, where accredited programs with flexible learning and funding opportunities are essential. For those seeking such options, attending accredited medical billing and coding schools with financial aid can make career changes more accessible and affordable.

Some learners prefer clinical roles but may wish to avoid standardized testing requirements. For these individuals, enrolling in a nursing school that don't require teas can help streamline the application process and reduce barriers to entry.

Those interested in leadership or administration might consider completing a best online healthcare administration degree, which equips graduates with essential management skills for the evolving healthcare landscape. Nurses aiming for advanced practice may be interested in bridge programs such as asn to fnp, creating clear pathways to become family nurse practitioners efficiently. These alternatives support diverse goals and make entering the medical field more achievable.

Best Scientists Citing Thomas A. D'Amico

Trending Scientists

Recently Published Articles